Literature DB >> 18981475

Parathyroid hormone signaling through low-density lipoprotein-related protein 6.

Mei Wan1, Chaozhe Yang, Jun Li, Xiangwei Wu, Hongling Yuan, Hairong Ma, Xi He, Shuyi Nie, Chenbei Chang, Xu Cao.   

Abstract

Intermittent administration of PTH stimulates bone formation, but the precise mechanisms responsible for PTH responses in osteoblasts are only incompletely understood. Here we show that binding of PTH to its receptor PTH1R induced association of LRP6, a coreceptor of Wnt, with PTH1R. The formation of the ternary complex containing PTH, PTH1R, and LRP6 promoted rapid phosphorylation of LRP6, which resulted in the recruitment of axin to LRP6, and stabilization of beta-catenin. Activation of PKA is essential for PTH-induced beta-catenin stabilization, but not for Wnt signaling. In vivo studies confirmed that PTH treatment led to phosphorylation of LRP6 and an increase in amount of beta-catenin in osteoblasts with a concurrent increase in bone formation in rat. Thus, LRP6 coreceptor is a key element of the PTH signaling that regulates osteoblast activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981475      PMCID: PMC2577789          DOI: 10.1101/gad.1702708

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

1.  An LDL-receptor-related protein mediates Wnt signalling in mice.

Authors:  K I Pinson; J Brennan; S Monkley; B J Avery; W C Skarnes
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

Review 2.  New aspects of Wnt signaling pathways in higher vertebrates.

Authors:  J Huelsken; W Birchmeier
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

Review 3.  The promise and perils of Wnt signaling through beta-catenin.

Authors:  Randall T Moon; Bruce Bowerman; Michael Boutros; Norbert Perrimon
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

4.  LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.

Authors:  B Mao; W Wu; Y Li; D Hoppe; P Stannek; A Glinka; C Niehrs
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

5.  Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6.

Authors:  M V Semënov; K Tamai; B K Brott; M Kühl; S Sokol; X He
Journal:  Curr Biol       Date:  2001-06-26       Impact factor: 10.834

6.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow.

Authors:  A Bafico; G Liu; A Yaniv; A Gazit; S A Aaronson
Journal:  Nat Cell Biol       Date:  2001-07       Impact factor: 28.824

7.  The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein.

Authors:  Y Li; M P Marzolo; P van Kerkhof; G J Strous; G Bu
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

8.  Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Authors:  Xiaofeng Li; Yazhou Zhang; Heeseog Kang; Wenzhong Liu; Peng Liu; Jianghong Zhang; Stephen E Harris; Dianqing Wu
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

9.  Tcf/Lef transcription factors during T-cell development: unique and overlapping functions.

Authors:  F J Staal; H Clevers
Journal:  Hematol J       Date:  2000

10.  Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.

Authors:  J Mao; J Wang; B Liu; W Pan; G H Farr; C Flynn; H Yuan; S Takada; D Kimelman; L Li; D Wu
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

View more
  118 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

2.  Effects of age on parathyroid hormone signaling in human marrow stromal cells.

Authors:  Shuanhu Zhou; Ericka M Bueno; Sung Won Kim; Ilaria Amato; Longxiang Shen; Jochen Hahne; Ilan Bleiberg; Paul Morley; Julie Glowacki
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

Review 3.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 4.  Signaling pathways affecting skeletal health.

Authors:  Pierre J Marie
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

5.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

6.  Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice.

Authors:  Gang-Qing Yao; Jian-Jun Wu; Nancy Troiano; Karl Insogna
Journal:  J Bone Miner Metab       Date:  2010-07-03       Impact factor: 2.626

7.  Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.

Authors:  S Deasey; D Nurminsky; S Shanmugasundaram; F Lima; M Nurminskaya
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

8.  Parathyroid hormone-related protein activates Wnt signaling to specify the embryonic mammary mesenchyme.

Authors:  Minoti Hiremath; Pamela Dann; Jennifer Fischer; Daniela Butterworth; Kata Boras-Granic; Julie Hens; Joshua Van Houten; Wei Shi; John Wysolmerski
Journal:  Development       Date:  2012-10-03       Impact factor: 6.868

Review 9.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

10.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.